When comparing the serum levels of these molecules and pro- and anti-inflammatory cytokines in T1D patients and healthy individuals, our results indicated significantly lower levels of perforin and granulysin in the T1D patient group. The gene discussed is GNLY; the disease is type 1 diabetes mellitus.